Cite
HARVARD Citation
Campagna, J. et al. (2018). A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model. Scientific reports. 8 (1), pp. 1-15. [Online].